Dr. Linda Joosten Presents: The FRAIL-AF randomized controlled trial September 5, 2023 Disclosures: TBD
Dr. Robert Mentz and Dr. C. Michael Gibson Discuss: HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency August 26, 2023 Disclosures: TBD
Dr. Thomas Tu, Dr. Mitchell Silver, Dr. Jay Giri, Dr. Wissam Jaber, and Dr. C. Michael Gibson Discuss: Reducing High-risk PE Mortality: A FLAME Town Hall July 12, 2023 Disclosures: TBD
Dr. Dominick Angiolillo and Dr. C. Michael Gibson Discuss: Academic Research Consortium (ARC) definitions surrounding reductions in dose, switches between agents and discontinuation of thienopyridines June 28, 2023 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Outcomes for Primary Prevention Patients in the CLEAR Outcomes Trial June 27, 2023 Disclosures: TBD
Dr. Barry Borlaug and Dr. C. Michael Gibson Discuss: CAMEO-DAPA Trial: Evaluation of the Mechanism of Benefit For Dapagliflozin in Heart Failure With Preserved Ejection Fraction: An Invasive Hemodynamic Randomized Trial March 6, 2023 Disclosures: TBD
Dr. Hyo-Soo Kim and Dr. C. Michael Gibson Discuss: Comparison of 3-month Versus 12-month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts And Advanced Polymer Technology: The HOST-IDEA Randomized Clinical Trial March 5, 2023 Disclosures: TBD
Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: Transcatheter Edge-to-edge Repair of Functional Mitral Regurgitation in Heart Failure: Final Five-year Results From the COAPT Trial March 5, 2023 Disclosures: TBD
Dr. Enoch Akowuah and Dr. C. Michael Gibson Discuss: Minimally Invasive Versus Conventional Sternotomy For Mitral Valve Repair Surgery: An Expertise Based Multicentre Randomised Controlled Trial (UK Mini Mitral) March 5, 2023 Disclosures: TBD
Dr. Divaka Perera and Dr. C. Michael Gibson Discuss: Effect of Myocardial Viability, Percutaneous Coronary Intervention and Functional Recovery on Clinical Outcomes in the REVIVED-BCIS2 Randomized Trial March 4, 2023 Disclosures: TBD
